Literature DB >> 1729193

Cell-free system responsible for internal radiolabeling of glycopeptidolipids of the Mycobacterium avium complex.

N Ramasesh1, E L Wright, W W Barrow.   

Abstract

Internal radiolabeling of serotype-specific glycopeptidolipids with [14C]mannose was accomplished with a cell-free system derived from serotype 20 of the Mycobacterium avium complex. Similar radiolabeling was not apparent with a cell-free system derived from the rough colony variant, previously shown to be devoid of glycopeptidolipids. Although a comparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis protein analysis of the parent and rough variant strains revealed a close similarity, there were some proteins unique to the parent strain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729193      PMCID: PMC257537          DOI: 10.1128/iai.60.1.308-311.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Mycobacterial glycolipids: isolation, structures, antigenicity, and synthesis of neoantigens.

Authors:  M McNeil; D Chatterjee; S W Hunter; P J Brennan
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

Review 2.  Contributing factors of pathogenesis in the Mycobacterium avium complex.

Authors:  W W Barrow
Journal:  Res Microbiol       Date:  1991-05       Impact factor: 3.992

3.  Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens.

Authors:  W W Barrow; P J Brennan
Journal:  J Bacteriol       Date:  1982-04       Impact factor: 3.490

4.  Macrophage uptake and retention of radiolabeled glycopeptidolipid antigens associated with the superficial L1 layer of Mycobacterium intracellulare serovar 20.

Authors:  L C Hooper; M M Johnson; V R Khera; W W Barrow
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

5.  Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.

Authors:  N Rastogi; K S Goh; H L David
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

6.  Identification and composition of turnip root lipids.

Authors:  M Lepage
Journal:  Lipids       Date:  1967-05       Impact factor: 1.880

7.  Inhibition of glycopeptidolipid synthesis resulting from treatment of Mycobacterium avium with 2-deoxy-D-glucose.

Authors:  E L Wright; W W Barrow
Journal:  Res Microbiol       Date:  1991-06       Impact factor: 3.992

8.  Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.

Authors:  A J Crowle; N Elkins; M H May
Journal:  Am Rev Respir Dis       Date:  1988-05

9.  A fluorescent staining procedure for determining the viability of mycobacterial cells.

Authors:  J T Kvach; J R Veras
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-06

10.  Radiolabelling of Mycobacterium avium oligosaccharide determinant and use in macrophage studies.

Authors:  J L Woodbury; W W Barrow
Journal:  J Gen Microbiol       Date:  1989-07
View more
  3 in total

1.  Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.

Authors:  W W Barrow; E L Wright; K S Goh; N Rastogi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

2.  Search for the molecular basis of morphological variation in Mycobacterium avium.

Authors:  S Prinzis; B Rivoire; P J Brennan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

3.  Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.

Authors:  N Rastogi; K S Goh; E L Wright; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.